News | Radiation Therapy | May 06, 2022

Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies

Accuray Incorporated announced that its ClearRT helical fan-beam kVCT imaging capability for the Radixact System has been selected as the winner of the “Best New Technology Solution for Oncology” award in the sixth annual MedTech Breakthrough Awards program

May 6, 2022 — Accuray Incorporated announced that its ClearRT helical fan-beam kVCT imaging capability for the Radixact System has been selected as the winner of the “Best New Technology Solution for Oncology” award in the sixth annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough. An independent market intelligence organization, MedTech Breakthrough recognizes the top companies, technologies and products in the global health and medical technology market.

The Accuray TomoTherapy System ushered in a new era in cancer care with 3D imageguided radiotherapy to improve treatment delivery. The Radixact System, the latest evolution of the TomoTherapy platform, in combination with ClearRT, makes it practical for radiation oncology departments of all sizes to easily, quickly and cost effectively acquire diagnostic-like quality CT images when treating tumors with radiation. The ClearRT technology is designed to provide higher quality imaging that improves the precision and accuracy of radiation treatment delivery.

ClearRT offers enhanced imaging capabilities compared to conventional linear accelerators that rely on cone-beam CT (CBCT) imaging, and provides an alternative to MR-based radiotherapy systems that are contraindicated for some patients, such as those with metal implants, and cost prohibitive to use. ClearRT also integrates with other Accuray applications, such as Synchrony, which adapts treatment delivery to tumor motion in real time as the patient breathes naturally, without uncomfortable patient restraints, breath-hold techniques, or interrupting treatment.

“The entire Accuray team is honored by this recognition from MedTech Breakthrough that reflects our heritage of developing innovative, ‘breakthrough’ technologies that truly advance patient care. ClearRT is the most recent example of an Accuray proprietary solution that is making it possible for our customers to do more, better and faster, when delivering radiation therapy treatments,” said Joshua H. Levine, chief executive officer of Accuray. “Ultimately, it’s about patients. We believe they should have more time with the people they love and doing the activities they enjoy and spend less time undergoing treatment.”

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Virtual Care, Medical Devices, Medical Data and many more. This year’s program attracted more than 3,900 nominations from over 15 different countries throughout the world.

“Advances in imaging are critical to increasing the precision and accuracy of the radiation dose delivered, and high-quality images are central to each step of the entire radiotherapy treatment workflow,” said James Johnson, managing director, MedTech Breakthrough. “The Radixact System along with ClearRT from Accuray has the potential to change the field of radiation oncology. This ‘breakthrough’ imaging technology will allow teams to improve care via better visualization of tumors while also shortening treatment times. Congratulations to the Accuray team for taking home this 2022 MedTech Breakthrough Award.”

For more information:

Related Content

News | Radiation Therapy

March 31, 2023 — Varian, a Siemens Healthineers company, shared two key milestones as its users continue to adopt the ...

Time March 31, 2023
News | Radiation Therapy

March 28, 2023 — People exposed to low doses of ionizing radiation have an extra, but modest, risk of developing heart ...

Time March 28, 2023
News | Lung Imaging

March 27, 2023 — On Target Laboratories, Inc., a privately held biotechnology company developing intraoperative ...

Time March 27, 2023
News | PET Imaging

March 23, 2023 — Nuclidium announced that the Neuroendocrine Tumors Research Foundation (NETRF) has selected the company ...

Time March 24, 2023
News | Lung Imaging

March 22, 2023 — The Riverain Technologies ClearRead Bone Suppression solution is now available on the Siemens ...

Time March 22, 2023
News | Quality Assurance (QA)

March 16, 2023 — RTsafe, a leading provider of quality assurance products and services in stereotactic radiosurgery ...

Time March 16, 2023
News | Lung Imaging

March 15, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...

Time March 15, 2023
News | Radiation Oncology

March 14, 2023 — Elekta announced that is has signed a joint venture with China National Pharmaceutical Group Co., Ltd. ...

Time March 14, 2023
News | Digital Pathology

March 13, 2023 — Proscia, a leading provider of digital and computational pathology solutions, today announced that ...

Time March 13, 2023
Feature | Radiology Business | By Christine Book

With an increasing focus on personalizing the patient experience and enhancing communication between radiologists and ...

Time March 10, 2023
Subscribe Now